Viewing nowCombinationTelmidiquat Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
HanDoc Co., Ltd.

MFDS item code 201605769 · Approved 2016.09.30 · Insurance code 652105640
Improvement in blood pressure control in essential hypertension with combination of Amlodipine or Telmisartan
This medication is helpful for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Amlodipine or Telmisartan. It effectively lowers blood pressure and is used to reduce the risk of cardiovascular disease.
The recommended dosage of this medication is 1 tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., morning). For patients with renal impairment, initiation of treatment should start with a lower dose in severe cases, with gradual titration. For patients with liver impairment, the daily dosage should not exceed 40 mg. Elderly patients should start treatment with a lower dose and gradually increase the dosage.
Safety and efficacy have not been established for pediatric patients under 18 years of age, hence use of this medication is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. This medication is contraindicated in women who are pregnant or breastfeeding, and in patients with severe issues with the liver or heart, or those who are allergic to the active ingredient or similar components. Patients with compromised liver function, heart valve issues, reduced kidney function, and the elderly should use this medication with special caution. Common side effects include dizziness and swelling, and while serious side effects may occur rarely, immediate consultation with a physician is required upon observing any unusual symptoms. Blood pressure may drop too low, so patients, especially those who are deficient in fluids or salt, should check their condition before taking the medication and follow the physician's instructions. Due to the risk of increased potassium levels, potassium-rich drugs or supplements should be monitored with regular blood tests for potassium levels during use. Patients with weak kidney function should regularly monitor their kidney function and electrolyte levels while taking this medication. Due to strong blood pressure-lowering effects, patients should be cautious of dizziness or drowsiness while driving or operating dangerous machinery. Drug interactions may occur when taken with other medications, so inform healthcare professionals of all other medications being taken. In case of overdose, severe hypotension or cardiac issues can occur, requiring immediate medical treatment. The safety and efficacy of this medication have not been established in children, and dosage adjustments may be necessary in the elderly. This medication should be kept out of reach of children and should only be opened immediately before administration.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly sealed container that protects it from light. The storage temperature should be maintained between 1 degree and 30 degrees Celsius for optimal efficacy.
Biconvex oval double tablet in white and light gray
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
HanDoc Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.